| Control |  |  |  | Ro-32-0432 |  |  |  |
---|
 | RMCA |  | LMCA |  | RMCA |  | LMCA |  |
---|
 | Emax(%) | pEC50 | Emax(%) | pEC50 | Emax(%) | pEC50 | Emax(%) | pEC50 |
---|
S6c
| 21 ± 4 | 8.38 ± 0.30 | 3 ± 2** | 6.81 ± 0.01* | 7 ± 2* | 7.43 ± 0.59 | 5 ± 3** | 6.89 ± 0.16 |
ET-1
| 238 ± 19 | 7.62 ± 0.14 | 253 ± 28 | 7.49 ± 0.13 | 278 ± 11 | 7.54 ± 0.09 | 187 ± 12†| 7.72 ± 0.31 |
- Contractile responses to sarafotoxin 6c (S6c) and endothelin-1 (ET-1) in the right and the left MCA 24 hours after MCAO. Emax is expressed as percent of K+ induced contractions and pEC50 values represent negative logarithm of the agonist concentration producing half maximum response. *P < 0.05, **P < 0.01 compared to control RMCA. †P < 0.05 compared to Ro-32-0432 RMCA.